Best practice guidelines on genetic diagnostics of Facioscapulohumeral muscular dystrophy: Workshop 9th June 2010, LUMC, Leiden, The Netherlands

During the 171st European Neuromuscular Centre international workshop Standards of care and management of facioscapulohumeral muscular dystrophy (FSHD) in January 2010 [1], it was concluded that there was a need for further discussion to better define the “gold standard” for diagnostic procedures for FSHD. With the increasing complexity of the genetics of FSHD, it is important to reach an international consensus on the molecular testing methods. To this end, a meeting was held with 39 scientists from around the world at the Leiden University Medical Center on June 9, 2010 to establish consensus Best Practice Guidelines on Genetic Diagnosis of FSHD.

[1]  Daniel G. Miller,et al.  A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy , 2010, Science.

[2]  K. Mathews.  Facioscapulohumeral Muscular Dystrophy: Clinical Medicine and Molecular Cell Biology. , 2005 .

[3]  B. Engelen,et al.  171st ENMC International Workshop: Standards of care and management of facioscapulohumeral muscular dystrophy , 2010, Neuromuscular Disorders.

[4]  E. Bakker,et al.  Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis , 2001, Annals of neurology.

[5]  Rabi Tawil,et al.  Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. , 2011, Trends in molecular medicine.

[6]  M. Ehrlich,et al.  FSH dystrophy and a subtelomeric 4q haplotype: a new assay and associations with disease , 2010, Journal of Medical Genetics.

[7]  M. Ehrlich,et al.  Hybridization analysis of D4Z4 repeat arrays linked to FSHD , 2007, Chromosoma.

[8]  R. Frants,et al.  Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. , 2004, American journal of human genetics.

[9]  R. Tawil,et al.  Facioscapulohumeral muscular dystrophy , 2006, Muscle & nerve.

[10]  J. Pouget,et al.  Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy , 2011, Annals of neurology.

[11]  M. Tarnopolsky,et al.  Clinical features of facioscapulohumeral muscular dystrophy 2 , 2010, Neurology.

[12]  G. Deidda,et al.  Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). , 1996, Journal of medical genetics.

[13]  L. Sandkuijl,et al.  De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. , 2000, American journal of human genetics.

[14]  C. Wijmenga,et al.  The FSHD‐linked locus D4F104S1 (p13E‐11) ON 4q35 has a homologue on 10qter , 1995, Muscle & nerve. Supplement.

[15]  R. Frants,et al.  Genetic confirmation of facioscapulohumeral muscular dystrophy in a case with complex D4Z4 rearrangments , 2005, Human Genetics.

[16]  Y. Hayashi,et al.  Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy , 2006, Neuromuscular Disorders.

[17]  E. Bakker,et al.  Somatic mosaicism in FSHD often goes undetected , 2004, Annals of neurology.

[18]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[19]  Y. Hayashi,et al.  Chromosome 4q;10q translocations; Comparison with different ethnic populations and FSHD patients , 2002, BMC neurology.

[20]  M. Barat‐Houari,et al.  New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination? , 2010, European Journal of Human Genetics.

[21]  P. de Knijff,et al.  Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. , 2007, American journal of human genetics.

[22]  D. Cooper,et al.  D4F104S1 deletion in facioscapulohumeral muscular dystrophy , 2003, Neurology.

[23]  D. Cooper,et al.  Facioscapulohumeral Muscular Dystrophy : Clinical Medicine and Molecular Cell Biology , 2004 .

[24]  P. de Knijff,et al.  Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution. , 2010, American journal of human genetics.

[25]  M. Zatz,et al.  Equal proportions of affected cells in muscle and blood of a mosaic carrier of facioscapulohumeral muscular dystrophy , 2006, Human Genetics.

[26]  G. V. Ommen,et al.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere , 2002, Nature Genetics.

[27]  G. V. Ommen,et al.  Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy , 2003, Nature Genetics.